Top

Published in:

01-07-2011 | Review

Metastatic lymph node 51 and fibroblast-like synoviocyte hyperproliferation in rheumatoid arthritis pathogenesis

Authors: Dae-Seog Lim, Yong-Soo Bae

Published in: Rheumatology International | Issue 7/2011

Abstract

One of the varied characteristic features of the pathogenesis of rheumatoid arthritis (RA) is synovial hyperplasia. Fibroblast-like synoviocytes (FLSs) play a key role in the development of sustained inflammation in arthritic joints. We have reported previously that metastatic lymph node 51 (MLN51) is involved in the proliferation of FLSs in the pathogenesis of RA. Interestingly, the overexpression of MLN51 was observed only in RA FLSs, but not in osteoarthritis FLSs, possibly expecting that MLN51 may be a RA-specific marker. Additionally, we found that granulocyte–macrophage colony-stimulating factor signaling activates mitogen-activated protein kinase, followed by the upregulation of MLN51 and FLICE-inhibitory protein, resulting in FLS hyperplasia in RA. Based on these studies, we could be firm that MLN51 is a key factor in FLS hyperplasia of RA patients.

Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907–916PubMedCrossRef

Houssiau FA (1995) Cytokines in rheumatoid arthritis. Clin Rheumatol 14(Suppl 2):10–13PubMedCrossRef

Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA (1988) Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31:1041–1045PubMedCrossRef

Chikanza IC, Kingsley G, Panayi GS (1995) Peripheral blood and synovial fluid monocyte expression of interleukin 1 alpha and 1 beta during active rheumatoid arthritis. J Rheumatol 22:600–606PubMed

Gitter BD, Labus JM, Lees SL, Scheetz ME (1989) Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha. Immunology 66:196–200PubMed

Shingu M, Nagai Y, Isayama T, Naono T, Nobunaga M (1993) The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin Exp Immunol 94:145–149PubMedCrossRef

Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586–1593PubMedCrossRef

Feldmann M (2001) Pathogenesis of arthritis: recent research progress. Nat Immunol 2:771–773PubMedCrossRef

Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 343:1594–1602PubMedCrossRef

10.

van Roon JA, van Roy JL, Gmelig-Meyling FH, Lafeber FP, Bijlsma JW (1996) Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 39:829–835PubMedCrossRef

11.

Sugiyama E, Kuroda A, Taki H, Ikemoto M, Hori T, Yamashita N, Maruyama M, Kobayashi M (1995) Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol 22:2020–2026PubMed

12.

Smith RS, Smith TJ, Blieden TM, Phipps RP (1997) Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 151:317–322PubMed

13.

Pap T, Muller-Ladner U, Gay RE, Gay S (2000) Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2:361–367PubMedCrossRef

14.

Paleolog EM, Miotla JM (1998) Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target. Angiogenesis 2:295–307PubMedCrossRef

15.

Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356–361PubMedCrossRef

16.

Yoshihara Y, Yamada H (2007) Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis. Clin Calcium 17:500–508PubMed

17.

Obermajer N, Jevnikar Z, Doljak B, Kos J (2008) Role of cysteine cathepsins in matrix degradation and cell signalling. Connect Tissue Res 49:193–196PubMedCrossRef

18.

Kramer I, Wibulswas A, Croft D, Genot E (2003) Rheumatoid arthritis: targeting the proliferative fibroblasts. Prog Cell Cycle Res 5:59–70PubMed

19.

Degot S, Regnier CH, Wendling C, Chenard MP, Rio MC, Tomasetto C (2002) Metastatic Lymph Node 51, a novel nucleo-cytoplasmic protein overexpressed in breast cancer. Oncogene 21:4422–4434PubMedCrossRef

20.

Jang J, Lim DS, Choi YE, Jeong Y, Yoo SA, Kim WU, Bae YS (2006) MLN51 and GM-CSF involvement in the proliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 8:R170PubMedCrossRef

21.

Varis A, Wolf M, Monni O, Vakkari ML, Kokkola A, Moskaluk C, Frierson H Jr, Powell SM, Knuutila S, Kallioniemi A, El-Rifai W (2002) Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 62:2625–2629PubMed

22.

Degot S, Le Hir H, Alpy F, Kedinger V, Stoll I, Wendling C, Seraphin B, Rio MC, Tomasetto C (2004) Association of the breast cancer protein MLN51 with the exon junction complex via its speckle localizer and RNA binding module. J Biol Chem 279:33702–33715PubMedCrossRef

23.

Tange TO, Shibuya T, Jurica MS, Moore MJ (2005) Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core. RNA 11:1869–1883PubMedCrossRef

24.

Dreyfuss G, Kim VN, Kataoka N (2002) Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 3:195–205PubMedCrossRef

25.

Wiegand HL, Lu S, Cullen BR (2003) Exon junction complexes mediate the enhancing effect of splicing on mRNA expression. Proc Natl Acad Sci U S A 100:11327–11332PubMedCrossRef

26.

Tomasetto C, Regnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P, Rio MC (1995) Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11–q21.3 region of chromosome 17. Genomics 28:367–376PubMedCrossRef

27.

Ha JE, Choi YE, Jang J, Yoon CH, Kim HY, Bae YS (2008) FLIP and MAPK play crucial roles in the MLN51-mediated hyperproliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis. FEBS J 275:3546–3555PubMedCrossRef

28.

Yamanishi Y, Firestein GS (2001) Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum Dis Clin North Am 27:355–371PubMedCrossRef

29.

Ahn JH, Lee Y, Jeon C, Lee SJ, Lee BH, Choi KD, Bae YS (2002) Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis. Blood 100:1742–1754PubMed

30.

Goodall GJ, Bagley CJ, Vadas MA, Lopez AF (1993) A model for the interaction of the GM-CSF, IL-3 and IL-5 receptors with their ligands. Growth Factors 8:87–97PubMedCrossRef

31.

Trapnell BC, Whitsett JA (2002) Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 64:775–802PubMedCrossRef

32.

Gearing DP, King JA, Gough NM, Nicola NA (1989) Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J 8:3667–3676PubMed

33.

Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A (1990) Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci U S A 87:9655–9659PubMedCrossRef

34.

Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, Griffin JD, Ihle JN (1994) JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335–4341PubMed

35.

Matsuguchi T, Zhao Y, Lilly MB, Kraft AS (1997) The cytoplasmic domain of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha subunit is essential for both GM-CSF-mediated growth and differentiation. J Biol Chem 272:17450–17459PubMedCrossRef

36.

Duronio V, Clark-Lewis I, Federsppiel B, Wieler JS, Schrader JW (1992) Tyrosine phosphorylation of receptor beta subunits and common substrates in response to interleukin-3 and granulocyte-macrophage colony-stimulating factor. J Biol Chem 267:21856–21863PubMed

37.

Sakamaki K, Miyajima I, Kitamura T, Miyajima A (1992) Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J 11:3541–3549PubMed

38.

Watanabe S, Itoh T, Arai K (1996) Roles of JAK kinases in human GM-CSF receptor signal transduction. J Allergy Clin Immunol 98:S183–S191PubMedCrossRef

39.

Hackenmiller R, Kim J, Feldman RA, Simon MC (2000) Abnormal stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/- mice. Immunity 13:397–407PubMedCrossRef

40.

Inoue T, Hammaker D, Boyle DL, Firestein GS (2005) Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes. J Immunol 174:4301–4306PubMed

41.

Schett G, Tohidast-Akrad M, Smolen JS, Schmid BJ, Steiner CW, Bitzan P, Zenz P, Redlich K, Xu Q, Steiner G (2000) Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 43:2501–2512PubMedCrossRef

42.

Aupperle KR, Boyle DL, Hendrix M, Seftor EA, Zvaifler NJ, Barbosa M, Firestein GS (1998) Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol 152:1091–1098PubMed

43.

Lories RJ, Derese I, Ceuppens JL, Luyten FP (2003) Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 48:2807–2818PubMedCrossRef

44.

Palao G, Santiago B, Galindo M, Paya M, Ramirez JC, Pablos JL (2004) Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. Arthritis Rheum 50:2803–2810PubMedCrossRef

45.

Safa AR, Day TW, Wu CH (2008) Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy. Curr Cancer Drug Targets 8:37–46PubMedCrossRef

46.

Kataoka T (2005) The caspase-8 modulator c-FLIP. Crit Rev Immunol 25:31–58PubMedCrossRef

47.

Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, Tschopp J (2000) The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 10:640–648PubMedCrossRef

48.

Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L (2000) Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene 19:4451–4460PubMedCrossRef

49.

Imamura R, Konaka K, Matsumoto N, Hasegawa M, Fukui M, Mukaida N, Kinoshita T, Suda T (2004) Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha. J Biol Chem 279:46415–46423PubMedCrossRef

50.

Miyazawa K, Mori A, Okudaira H (1998) Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen. J Biochem 124:1153–1162PubMed

Title: Metastatic lymph node 51 and fibroblast-like synoviocyte hyperproliferation in rheumatoid arthritis pathogenesis
Authors: Dae-Seog Lim
Yong-Soo Bae
Publication date: 01-07-2011
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 7/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-011-1818-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Metastatic lymph node 51 and fibroblast-like synoviocyte hyperproliferation in rheumatoid arthritis pathogenesis

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2011

Lupus anticoagulant in a child with celiac disease: a rare association

Erratum to: The role of intra-articular hyaluronan (Sinovial®) in the treatment of osteoarthritis

Autoinflammatory disorders and patients with isolated serosal involvement

The effects of shockwave on systemic concentrations of nitric oxide level, angiogenesis and osteogenesis factors in hip necrosis

MEFV gene mutations and its impact on the clinical course in ulcerative colitis patients

Anabolic androgenic steroid induced necrotising myopathy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page